JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 6, 2004; DOI: 10.1124/jpet.104.067157


0022-3565/04/3103-1190-1198$20.00
JPET 310:1190-1198, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.067157v1
310/3/1190    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudary, N.
Right arrow Articles by Coe, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudary, N.
Right arrow Articles by Coe, I. R.

CARDIOVASCULAR

The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase C{epsilon} in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1

Naz Chaudary, Zlatina Naydenova, Irina Shuralyova, and Imogen R. Coe

Department of Biology, York University, Toronto, Ontario, Canada

Brief exposure of the heart to hypoxia results in less cellular damage after subsequent hypoxia, an effect known as preconditioning (PC). PC has been widely studied but is still not fully understood. Adenosine (Ado), adenosine receptors, and protein kinase C (PKC) have been implicated as integral components of PC. Adenosine (nucleoside) transporters (NTs) facilitate flux of Ado across cell membranes, but their role in PC is unknown. Therefore, we used the murine cardiomyocyte cell line, HL-1, and asked if there was feedback regulation of NTs by Ado, Ado receptors, and PKC following either hypoxic or pharmacological PC. Activation (by specific agonists) of A1 or A3 Ado receptors or PKC resulted in PC in HL-1. The A1 (but not A3) receptor is coupled to PKC{epsilon}, and activation of PKC{epsilon} (by specific peptide agonist) resulted in PC. Moreover, PKC{epsilon} stimulates Ado uptake via the predominant NT in HL-1, mouse equilibrative nucleoside transporter 1 (mENT1). Studies in primary neonatal mouse cardiomyocytes confirmed our observations in HL-1 cells. Hypoxic challenge led to a rapid increase in, and efflux of, intracellular Ado from cells, which was blocked by NT inhibitors (dipyridamole/nitrobenzylthioinosine). Moreover, NT inhibition during hypoxia or PC was highly protective, suggesting that Ado loss contributes to decreased cell viability. Our data suggest that hypoxic challenge causes an efflux of Ado via ENTs, activation of A1 and/or A3 receptors, signaling through PKC{epsilon}, and activation of ENT1. Since Ado is required for ATP synthesis on reperfusion, this feedback regulation of mENT1 would promote reuptake of Ado.


Received February 17, 2004; accepted May 6, 2004.

Address correspondence to: Imogen R. Coe, Department of Biology, York University, 4700 Keele St., Toronto, Ontario, Canada M3J 1P3. E-mail: coe{at}yorku.ca




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
E. N. Churchill, M.-H. Disatnik, G. R. Budas, and D. Mochly-Rosen
Ethanol for cardiac ischemia: the role of protein kinase c
Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 469 - 483.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Naydenova, J. B. Rose, and I. R. Coe
Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2687 - H2692.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. B. Rose and I. R. Coe
Physiology of Nucleoside Transporters: Back to the Future. . . .
Physiology, February 1, 2008; 23(1): 41 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Patzak, E. Y. Lai, M. Fahling, M. Sendeski, P. Martinka, P. B. Persson, and A. E. G. Persson
Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2232 - R2242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Valdes, W. Liu, B. Ullman, and S. M. Landfear
Comprehensive Examination of Charged Intramembrane Residues in a Nucleoside Transporter
J. Biol. Chem., August 11, 2006; 281(32): 22647 - 22655.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Gorlach
Control of Adenosine Transport by Hypoxia
Circ. Res., July 8, 2005; 97(1): 1 - 3.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. J. Endres and J. D. Unadkat
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S6-(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole
Mol. Pharmacol., March 1, 2005; 67(3): 837 - 844.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.